With October being Breast Cancer Awareness Month, there has been a wash of pink over every product out there. A recent advancement in breast cancer treatment, however, isn’t pink at all.
James V. Pellicane, M.D., F.A.C.S., co-founder of Bon Secours Virginia Breast Center and director of breast oncology at the Bon Secours Cancer Institute in Richmond, has helped pioneer the use of a new device called BioZorb. The BioZorb marker is placed in the breast during lumpectomy surgery and identifies where the tumor was removed in a fixed 3-D array . The marker then helps the oncologist more reliably determine where to aim the radiation. The spiral shaped marker is then absorbed into the body over the course of a year or more, leaving the marker clips in place so the site can be identified more easily in long term monitoring.
The BioZorb improves the treatment of breast cancer by more precisely targeting radiation treatment and providing for better follow-up exams.Dr. Pellicane answered a few of our questions about BioZorb.
Rmom: When did you begin using BioZorb with your patients, and how many patients in Richmond have been treated using this device?
Dr.Pellicane: We began using BioZorb about 5 months ago and have used it in about 25 patients.
Rmom: What advantages do BioZorb markers offer the oncologist treating the patient that other markers do not?
Dr.Pellicane: It is a 3-dimensional marker, where as the others are not; it also acts as a scaffolding in the breast to help improve the cosmetic outcome. It’s also absorbed into the breast tissue –leaving 6 titanium marking clips to mark the affected area. The dissolvable material is like that of absorbable sutures.
Rmom: What advantages does BioZorb offer the patient? Do patients need to be concerned about the markers migrating after BioZorb has dissolved?
Dr.Pellicane: One major advantage is the precise targeting of radiation. No need to worry about migration. It is sutured securely in place and scars in rather quickly.
Rmom: Will BioZorb be offered to every patient treated for breast cancer at Bon Secours Cancer Institute?
Dr.Pellicane: Every patient in which it makes sense and who is a good candidate will be offered the device. It is ultimately up to them.
Click here for more information about BioZorb technology.
To find out more about Bon Secours Cancer Institute visit them online here.
